- Facultat de Medicina
Centro
Hospital de Figueres
Figueres, EspañaPublicaciones en colaboración con investigadores/as de Hospital de Figueres (11)
2023
-
Sex and gender differences in acute stroke care: metrics, access to treatment and outcome. A territorial analysis of the Stroke Code System of Catalonia
European Stroke Journal, Vol. 8, Núm. 2, pp. 557-565
2022
-
Determinants and Trends of the Use of Intravenous Thrombolysis for Minor Stroke: A Population-Based Study, 2016 to 2020
Stroke, Vol. 53, Núm. 11, pp. 3289-3294
-
The Role of Vascular Imaging atReferral Centers in the Drip and Ship Paradigm
Journal of Stroke and Cerebrovascular Diseases, Vol. 31, Núm. 1
2020
-
Association of a single nucleotide polymorphism combination pattern of the Klotho gene with non-cardiovascular death in patients with chronic kidney disease
Clinical Kidney Journal, Vol. 13, Núm. 6, pp. 1017-1024
2019
-
Association of candidate gene polymorphisms with chronic kidney disease: Results of a case-control analysis in the NEFRONA cohort
Frontiers in Genetics, Vol. 10, Núm. FEB
2017
-
Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: The NEFRONA study
Nephrology Dialysis Transplantation, Vol. 32, Núm. 3, pp. 513-520
2015
-
Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease
Nephrology Dialysis Transplantation, Vol. 30, Núm. 7, pp. 1176-1185
-
Melanoma incidence increases in the elderly of Catalonia but not in the younger population: Effect of prevention or consequence of immigration?
Acta Dermato-Venereologica, Vol. 95, Núm. 4, pp. 422-426
-
Similar biological effect of high-dose oral versus intravenous methylprednisolone in multiple sclerosis relapses
Multiple Sclerosis Journal, Vol. 21, Núm. 5, pp. 646-650
-
Transdermal rotigotine improves sleep fragmentation in parkinson's disease: Results of the multicenter, prospective SLEEP-FRAM study
Parkinson's Disease, Vol. 2015
2014
-
A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS
Multiple Sclerosis Journal, Vol. 20, Núm. 6, pp. 717-725